Glycoconjugates, glycoamino acids, intermediates thereto,...

Details Glycoconjugates, glycoamino acids, intermediates thereto,... Glycoconjugates, glycoamino acids, intermediates thereto,...

2002-07-31

2010-12-21

Canella, Karen A (Department: 1643)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

C514S008100, C514S023000, C514S025000, C514S042000, C514S053000, C514S054000, C514S062000, C530S322000, C536S123100

Reexamination Certificate

active

07854934

ABSTRACT:
The present invention provides novel glycosides and glycoconjugates, glycoamino acids, and methods for the synthesis thereof. In another aspect, the present invention provides novel clustered glycopeptides and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, preferably for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need, an effective amount of any of the inventive glycopeptides as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier.

REFERENCES:
patent: 5053489 (1991-10-01), Kufe et al.
patent: 5212298 (1993-05-01), Rademacher et al.
patent: 5229289 (1993-07-01), Kjeldsen et al.
patent: 5280113 (1994-01-01), Rademacher et al.
patent: 5376531 (1994-12-01), Anderson et al.
patent: 5421733 (1995-06-01), Nudelman et al.
patent: 5491088 (1996-02-01), Hellerstrom et al.
patent: 5625030 (1997-04-01), Williams et al.
patent: 5660834 (1997-08-01), Kjeldsen et al.
patent: 5679769 (1997-10-01), Danishefsky
patent: 5683674 (1997-11-01), Taylor-Papadimitriou et al.
patent: 5747048 (1998-05-01), Kjeldsen et al.
patent: 5798090 (1998-08-01), Longenecker et al.
patent: 5807559 (1998-09-01), Jondal et al.
patent: 5858994 (1999-01-01), Kretzschmar et al.
patent: 5871990 (1999-02-01), Clausen et al.
patent: 5977081 (1999-11-01), Marciani
patent: 6013779 (2000-01-01), Wong et al.
patent: 6080725 (2000-06-01), Marciani
patent: 6090789 (2000-07-01), Danishefsky et al.
patent: 6222020 (2001-04-01), Taylor-Papadimitriou et al.
patent: 6238668 (2001-05-01), Danishefsky et al.
patent: 6355639 (2002-03-01), Chou et al.
patent: RE38046 (2003-03-01), Longenecker et al.
patent: 6544952 (2003-04-01), Danishefsky et al.
patent: 6548661 (2003-04-01), Danishefsky et al.
patent: 6660714 (2003-12-01), Danishefsky et al.
patent: 7018637 (2006-03-01), Chong et al.
patent: 7160856 (2007-01-01), Danishefsky et al.
patent: 7531181 (2009-05-01), Danishefsky et al.
patent: 7550146 (2009-06-01), Danishefsky et al.
patent: 7635750 (2009-12-01), Danishefsky et al.
patent: 7645454 (2010-01-01), Danishefsky et al.
patent: 2002/0006900 (2002-01-01), Danishefsky et al.
patent: 2002/0038017 (2002-03-01), Danishefsky et al.
patent: 2003/0153492 (2003-08-01), Danishefsky et al.
patent: 2004/0208884 (2004-10-01), Danishefsky et al.
patent: 2010/0081786 (2010-04-01), Danishefsky et al.
patent: 315153 (1989-05-01), None
patent: 315153 (1989-05-01), None
patent: 341252 (1997-11-01), None
patent: 8-319300 (1996-12-01), None
patent: WO 96/34005 (1996-10-01), None
patent: WO 96/40198 (1996-12-01), None
patent: WO 97/03995 (1997-02-01), None
patent: WO 98/30190 (1998-07-01), None
patent: WO 98/46246 (1998-10-01), None
patent: WO 98/52573 (1998-11-01), None
patent: WO-9852573 (1998-11-01), None
patent: WO 99/15201 (1999-04-01), None
patent: WO-9915201 (1999-04-01), None
patent: WO 99/48515 (1999-09-01), None
patent: WO-9948515 (1999-09-01), None
patent: WO 01/14395 (2001-03-01), None
patent: WO 01/14395 (2001-03-01), None
patent: WO 01/14395 (2001-03-01), None
patent: WO-01065261 (2001-09-01), None
patent: WO-2004011476 (2004-02-01), None
patent: WO-2004050711 (2004-06-01), None
patent: WO-200460915 (2004-07-01), None
patent: WO-2010006343 (2010-01-01), None
Abstract of Severin et al, Biokhimiya (Moscow), 1973, vol. 38, pp. 583-588.
Abstract of Grazi et al, Biochemical and Biophysical Research Communications, 1960, vol. 2, pp. 121-125).
Ferezou et al (Nutrition, 2001, vol. 17, pp. 930-933).
Abstract of Bischoff et al (International Archives of Allergy and Applied Immunology, 1984, vol. 75, pp. 20-26).
Warren et al, ‘Synthetic Glycopeptide-Based Vaccines’, In: Topics in Current Chemistry, 2007, vol. 267, pp. 109-141.
Ragupathi et al, Cancer Immunol lmmunother, 2003, vol. 52, pp. 608-616.
Orlandi et al, Clinical Cancer Research, 2007, vol. 13, pp. 6195-6203.
Gatza et al, Journal of Immunology, 2002, vol. 169, pp. 5227-5235.
Kedar and Klien, ‘Cancer Immunotherapy’, In: Advances in Cancer Research, 1992, vol. 59, pp. 245-322.
Keding and Danishefsky, PNAS, 2004, vol. 101, pp. 11937-11942.
Efferson et al (Anticancer research, 2005, vol. 25, pp. 715-724).
Bachman et al (Journal of Immunology, 2005, vol. 175, pp. 4677-4685).
Allen et al (JACS, 2001, vol. 123, pp. 1890-1897).
Gilewski et al (PNAS, Mar. 31, 2001, vol. 98, pp. 3270-3275).
Kim et al (Vaccine, 2001, vol. 19, pp. 530-537).
Chen et al., “Exploration of Modalities in Building a α-O-Linked Systems Through Glycal Assembly: A Total Synthesis of the Mucin-Related Flα Antigen”J. Am. Chem. Soc., 120, 7760-7769, 1998.
Kudryashov et al. “Immunogenicity of Synthetic Conjugates of LewisyOligosaccharide with Proteins in Mice: Towards the Design of Anticancer Vaccines,”Cancer Immunol Immunother, 45, 281-286, 1998.
Kuduk et al. “Synthetic and Immunological Studies on Clustered Modes of Mucin-Related Tn and TF O-Linked Antigens: The Preparation of a Glycopeptide-Based Vaccine for Clinical Trials against Prostate Cancer,”J. Am. Chem. Soc., 120, 12474-12485, 1998.
Liu et al., “Structurally Defined Synthetic Cancer Vaccines: Analysis of Structure, Glycosylation and Recognition of cancer Associated Mucin, MUC-1 Derived Peptides,”Glycoconjugate Journal, 12, 607-617.
Paulsen et al., “Sysnthesis of the Glycosyl Amino Acids . . . ,”Carbohydrate Research, 268, 17-34, 1995.
Qiu et al., “Mucin Type Glycopeptides: Synthesis of Core 2, Core 6 and Fl-α Building Blocks and Unexpected Reactions,”Tetrahedron Letters, 38(1), 45-48, 1997.
Sames et al., “Convergent Total Synthesis of a Tumor-Associated Mucin Motif,”Nature, 389, 587-591, 1997.
Toyokuni et al., “Synthetic Vaccines: Synthesis of a Dimeric Tn Antigen-Lipopeptide Conjugate that Elicits Immune Responses Against Tn-Expressing Glycoproteins,”J. Am. Chem. Soc., 116, 395-396, 1994.
Zhang, et al., “Selection of Tumor Agents as Targets for Immune Attack Using Immunohistochemistry: II. Blood Group Related Antigens,”Int. J. Cancer, 73, 50-56, 1997.
Allen et al., “Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1 , and Lewisyantigens”,J. Am. Chem. Soc., 123:1890-1897, 2001.
Allen et al., “A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: new application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages”,Chem. Eur. J., 6(8):1366-1375, 2000.
Biswas et al., “Construction of carbohydrate-based antitumor vaccines: synthesis of glycosyl amino acids by olefin cross-metathesis”,Tetrahedron Letters, 43:6107-6110, 2002.
Blackwell et al., “New approaches to olefin cross-metathesis”,J. Am. Chem. Soc., 122:58-71, 2000.
Bosse et al., “Linear synthesis of the tumor-associated carbohydrate antigens Globo-H, SSEA-3, and Gb3”,J. Org. Chem., 67:6659-6670, 2002.
Keding et al., “Hydroxynorleucine as a glycosyl acceptor is an efficient means for introducing amino acid functionality into complex carbohydrates”,Tetrahedron Letters, 44:3413-3416, 2003.
Kim et al., “Effect of immunological adjuvant combinations on the antibody and T-cell response to vaccination with MUC1-KLH and GD3-KLH conjugates”,Vaccine, 19:530-537, 2001.
Kudryashov et al., “Toward optimized carbohydrate-based anticancer vaccines: Epitope clustering, carrier structure, and adjuvant all influence antibody responses to lewisyconjugates in mice”,Proc. Natl. Acad. Sci. USA, 98:3264-3269, 2001.
Nicolaou et al., “A practical and enantioselective synthesis of glycosphingolipids and related compounds. Total synthesis of Globotriasosylceramide (Gb3)”,J. Am. Chem. Soc., 110:7910-7912, 1988.
Ragupathi etal., “A Fully synthetic Globo H carbohydrate vaccine induc

Affiliated with

Also associated with

Rating

Glycoconjugates, glycoamino acids, intermediates thereto,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycoconjugates, glycoamino acids, intermediates thereto,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoconjugates, glycoamino acids, intermediates thereto,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4214472